Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Article Dans Une Revue Neurobiology of Disease Année : 2022

Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response

Résumé

Anti-seizure medications (ASMs) are the first line of treatment for seizure control in children with epilepsy. Cumulative evidence suggests an imbalanced gut microbiota in refractory epilepsy patients. We systematically investigated the differential antimicrobial impacts of nine ASM active ingredients, seven common excipients of ASMs, and four syrup formulations on core early-life gut microbiota strains. Additionally, we evaluated the toxicity and gene expression profiles of HT-29 colon epithelial cells when exposed to active ingredients with or without bacterial supernatants. The physicochemical structure of ASM active ingredients and bacterial phylogeny were found to be related to ASM toxicity. Carbamazepine, lamotrigine, and topiramate reduced the growth of more than ten strains along with syrup excipient propyl-paraben. Various artificial sweeteners present in ASM formulations stimulated the growth of gut bacterial strains. The active ingredients that were more toxic to bacterial strains also exhibited toxicity towards HT-29 cells, yet Bifidobacterium longum supernatant reduced cytotoxic effects of carbamazepine and lamotrigine. Akkermansia muciniphila or mixed community supernatants reduced the expression of drug resistance genes in HT-29 cell lines. In summary, our results indicate that several ASM active ingredients and their excipients regulate the growth of gut bacterial strains in a species-specific manner. Interactions between ASMs and gut epithelial cells might be modulated by gut microbial metabolites.
Fichier principal
Vignette du fichier
2022_Ilhan_Exposure.pdf (3.64 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : CC BY NC ND - Paternité - Pas d'utilisation commerciale - Pas de modification

Dates et versions

hal-03954506 , version 1 (24-01-2023)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Zehra Esra Ilhan, Vincent Brochard, Nicolas Lapaque, Stéphane Auvin, Patricia Lepage. Exposure to anti-seizure medications impact growth of gut bacterial species and subsequent host response. Neurobiology of Disease, 2022, 167, pp.105664. ⟨10.1016/j.nbd.2022.105664⟩. ⟨hal-03954506⟩
42 Consultations
159 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More